Stay updated on Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:53:17.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T23:53:29.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Added site navigation/footer elements for Moffitt Clinical Trials, the sponsoring institution, Helpful Links, and access to drug/device information and study documents.
    Difference
    0.3%
    Check dated 2026-02-25T18:25:57.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page has a new site revision (v3.4.2) and several navigation/operational notices were removed, affecting metadata and links without altering study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-11T14:32:01.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    A government funding notice about potential delays and a page revision from v3.4.0 to v3.4.1 were added. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:38:48.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    Additions include a glossary toggle, Last Update Submitted that Met QC Criteria, Last Update Posted, a No FEAR Act Data disclosure, and Revision: v3.4.0. Deletions remove Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and Revision: v3.3.4; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T06:35:49.000Z thumbnail image

Stay in the know with updates to Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page.